Genome-Wide Analysis Unveils DNA Helicase RECQ1 as a Regulator of Estrogen Response Pathway in Breast Cancer Cells

Susceptibility to breast cancer is significantly increased in individuals with germ line mutations in RECQ1 (also known as RECQL or RECQL1), a gene encoding a DNA helicase essential for genome maintenance. We previously reported that RECQ1 expression predicts clinical outcomes for sporadic breast cancer patients stratified by estrogen receptor (ER) status. ABSTRACT Susceptibility to breast cancer is significantly increased in individuals with germ line mutations in RECQ1 (also known as RECQL or RECQL1), a gene encoding a DNA helicase essential for genome maintenance. We previously reported that RECQ1 expression predicts clinical outcomes for sporadic breast cancer patients stratified by estrogen receptor (ER) status. Here, we utilized an unbiased integrative genomics approach to delineate a cross talk between RECQ1 and ERα, a known master regulatory transcription factor in breast cancer. We found that expression of ESR1, the gene encoding ERα, is directly activated by RECQ1. More than 35% of RECQ1 binding sites were cobound by ERα genome-wide. Mechanistically, RECQ1 cooperates with FOXA1, the pioneer transcription factor for ERα, to enhance chromatin accessibility at the ESR1 regulatory regions in a helicase activity-dependent manner. In clinical ERα-positive breast cancers treated with endocrine therapy, high RECQ1 and high FOXA1 coexpressing tumors were associated with better survival. Collectively, these results identify RECQ1 as a novel cofactor for ERα and uncover a previously unknown mechanism by which RECQ1 regulates disease-driving gene expression in ER-positive breast cancer cells.

[1]  A. Arakawa,et al.  High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer , 2020, Breast Cancer Research and Treatment.

[2]  Sudha Sharma,et al.  RECQ1 Helicase in Genomic Stability and Cancer , 2020, Genes.

[3]  A. Prat,et al.  Frequency and spectrum of PIK3CA somatic mutations in breast cancer , 2020, Breast Cancer Research.

[4]  Roberto Vera Alvarez,et al.  BAMscale: quantification of next-generation sequencing peaks and generation of scaled coverage tracks , 2020, Epigenetics & Chromatin.

[5]  J. Gustafsson,et al.  Nuclear receptors: recent drug discovery for cancer therapies. , 2019, Endocrine reviews.

[6]  Sudha Sharma,et al.  The DNA repair helicase RECQ1 has a checkpoint-dependent role in mediating DNA damage responses induced by gemcitabine , 2019, The Journal of Biological Chemistry.

[7]  Henry W. Long,et al.  Estrogen receptor signaling is reprogrammed during breast tumorigenesis , 2019, Proceedings of the National Academy of Sciences.

[8]  J. Carroll,et al.  Comprehensive Genomic Analysis Reveals that the Pioneering Function of FOXA1 Is Independent of Hormonal Signaling , 2019, Cell reports.

[9]  M. Tischkowitz,et al.  Clinical implications of germline mutations in breast cancer genes: RECQL , 2019, Breast Cancer Research and Treatment.

[10]  Xiaoyan Zhang,et al.  Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis , 2018, Nucleic Acids Res..

[11]  M. Schmitz,et al.  Formaldehyde-assisted Isolation of Regulatory Elements to Measure Chromatin Accessibility in Mammalian Cells , 2018, Journal of visualized experiments : JoVE.

[12]  A. Cheema,et al.  A new sub‐pathway of long‐patch base excision repair involving 5′ gap formation , 2017, The EMBO journal.

[13]  B. Klein,et al.  RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma , 2017, Leukemia.

[14]  G. Ball,et al.  Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers , 2016, Molecular Cancer Therapeutics.

[15]  A. Lal,et al.  Transcriptome guided identification of novel functions of RECQ1 helicase. , 2016, Methods.

[16]  Roland Eils,et al.  Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..

[17]  J. Carroll.  Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer , 2016, European journal of endocrinology.

[18]  K. Kaestner,et al.  The Pioneer Transcription Factor FoxA Maintains an Accessible Nucleosome Configuration at Enhancers for Tissue-Specific Gene Activation. , 2016, Molecular cell.

[19]  Jing Huang,et al.  Catalytic Strand Separation by RECQ1 Is Required for RPA-Mediated Response to Replication Stress , 2015, Current Biology.

[20]  R. Gary,et al.  RECQ1 interacts with FEN-1 and promotes binding of FEN-1 to telomeric chromatin. , 2015, The Biochemical journal.

[21]  Yuntao Xie,et al.  Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer , 2015, PLoS genetics.

[22]  Aniruddh Kashyap,et al.  Germline RECQL mutations are associated with breast cancer susceptibility , 2015, Nature Genetics.

[23]  F. von Delft,et al.  Human RECQ1 helicase-driven DNA unwinding, annealing, and branch migration: Insights from DNA complex structures , 2015, Proceedings of the National Academy of Sciences.

[24]  Sudha Sharma.  An appraisal of RECQ1 expression in cancer progression , 2014, Front. Genet..

[25]  M. Goldberg,et al.  The DNA2 nuclease/helicase is an estrogen-dependent gene mutated in breast and ovarian cancers , 2014 .

[26]  P. Meltzer,et al.  Identification of RECQ1-regulated transcriptome uncovers a role of RECQ1 in regulation of cancer cell migration and invasion , 2014, Cell cycle.

[27]  K. Knudsen,et al.  Transcriptional Roles of PARP1 in Cancer , 2014, Molecular Cancer Research.

[28]  V. Bohr,et al.  Human RecQ helicases in DNA repair, recombination, and replication. , 2014, Annual review of biochemistry.

[29]  V. Bohr,et al.  Human RECQL1 participates in telomere maintenance , 2014, Nucleic acids research.

[30]  R. Brosh.  DNA helicases involved in DNA repair and their roles in cancer , 2013, Nature Reviews Cancer.

[31]  A. Stortchevoi,et al.  Human RECQ1 Interacts with Ku70/80 and Modulates DNA End-Joining of Double-Strand Breaks , 2013, PloS one.

[32]  A. Lal,et al.  Replication stress induces specific enrichment of RECQ1 at common fragile sites FRA3B and FRA16D , 2013, Molecular Cancer.

[33]  Neil D. Lawrence,et al.  Inference of RNA Polymerase II Transcription Dynamics from Chromatin Immunoprecipitation Time Course Data , 2013, PLoS Comput. Biol..

[34]  Sudha Sharma,et al.  Probing Genome Maintenance Functions of human RECQ1 , 2013, Computational and structural biotechnology journal.

[35]  M. Lopes,et al.  Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition , 2013, Nature Structural &Molecular Biology.

[36]  V. Bohr,et al.  RECQ1 is required for cellular resistance to replication stress and catalyzes strand exchange on stalled replication fork structures , 2012, Cell cycle.

[37]  M. Jasin,et al.  RECQ1 plays a distinct role in cellular response to oxidative DNA damage. , 2012, DNA repair.

[38]  J. Carroll,et al.  Pioneer factors in hormone-dependent cancers , 2012, Nature Reviews Cancer.

[39]  P. Giresi,et al.  Using formaldehyde-assisted isolation of regulatory elements (FAIRE) to isolate active regulatory DNA , 2012, Nature Protocols.

[40]  Ty C. Voss,et al.  Dynamic Exchange at Regulatory Elements during Chromatin Remodeling Underlies Assisted Loading Mechanism , 2011, Cell.

[41]  S. Bonin,et al.  The human RECQ1 helicase is highly expressed in glioblastoma and plays an important role in tumor cell proliferation , 2011, Molecular Cancer.

[42]  Rachel Schiff,et al.  Mechanisms of endocrine resistance in breast cancer. , 2011, Annual review of medicine.

[43]  W. Kraus,et al.  PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. , 2010, Molecular cell.

[44]  Adrian V. Lee,et al.  Proteasome inhibition represses ERα gene expression in ER+ cells- a new link between proteasome activity and estrogen signaling in breast cancer , 2009, Oncogene.

[45]  Robert L. Sutherland,et al.  Biological determinants of endocrine resistance in breast cancer , 2009, Nature Reviews Cancer.

[46]  Ian D. Hickson,et al.  RecQ helicases: multifunctional genome caretakers , 2009, Nature Reviews Cancer.

[47]  S. Ellison-Zelski,et al.  Repression of ESR1 through Actions of Estrogen Receptor Alpha and Sin3A at the Proximal Promoter , 2009, Molecular and Cellular Biology.

[48]  M. Lupien,et al.  Cistromics of hormone-dependent cancer. , 2009, Endocrine-related cancer.

[49]  Robert Gentleman,et al.  rtracklayer: an R package for interfacing with genome browsers , 2009, Bioinform..

[50]  G. Ball,et al.  Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. , 2008, European journal of cancer.

[51]  R. Brosh,et al.  Human RECQ1 Is a DNA Damage Responsive Protein Required for Genotoxic Stress Resistance and Suppression of Sister Chromatid Exchanges , 2007, PloS one.

[52]  J. Carroll,et al.  Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state , 2007, Nature Reviews Cancer.

[53]  D. Stumpo,et al.  RECQL, a Member of the RecQ Family of DNA Helicases, Suppresses Chromosomal Instability , 2006, Molecular and Cellular Biology.

[54]  K. Doherty,et al.  Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability. , 2006, The Biochemical journal.

[55]  Myles A Brown,et al.  Estrogen receptor target gene: an evolving concept. , 2006, Molecular endocrinology.

[56]  N. Lau,et al.  Characterization of the piRNA Complex from Rat Testes , 2006, Science.

[57]  Manal M. Hassan,et al.  Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. , 2006, Cancer research.

[58]  for the Statistics Subcommittee of the NCI—EORTC Worki Diagnostics.  REporting recommendations for tumor MARKer prognostic studies (REMARK) , 2005, Nature Clinical Practice Oncology.

[59]  A. Vindigni,et al.  Biochemical Analysis of the DNA Unwinding and Strand Annealing Activities Catalyzed by Human RECQ1*[boxs] , 2005, Journal of Biological Chemistry.

[60]  Clifford A. Meyer,et al.  Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1 , 2005, Cell.

[61]  Minetta C. Liu,et al.  Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling , 2003, Oncogene.

[62]  Thomas P. Yang,et al.  Role of the Promoter in Maintaining Transcriptionally Active Chromatin Structure and DNA Methylation Patterns In Vivo , 2003, Molecular and Cellular Biology.

[63]  G. Macino,et al.  Posttranscriptional gene silencing in Neurospora by a RecQ DNA helicase. , 1999, Science.

[64]  D. Ciocca,et al.  Estrogen Receptors and Cell Proliferation in Breast Cancer , 1997, Trends in Endocrinology & Metabolism.

[65]  J. Carroll,et al.  Chromatin Immunoprecipitation-Sequencing (ChIP-seq) for Mapping of Estrogen Receptor-Chromatin Interactions in Breast Cancer. , 2016, Methods in molecular biology.

[66]  A. Malovannaya,et al.  Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes , 2015 .

[67]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .